Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanjing Dichang Pharmaceutical Technology is a contract research and manufacturing organization (CRO/CDMO) headquartered in Nanjing, China. Established in 2014, the company specializes in the research, development, and production of pharmaceutical intermediates, fine chemicals, and advanced building blocks. Their technical expertise encompasses custom synthesis, process optimization, and the production of complex molecules such as chiral compounds and heterocyclic derivatives. Nanjing Dichang supports global pharmaceutical and biotechnology companies by providing high-quality chemical components essential for drug discovery and development. The firm operates dedicated R&D laboratories and pilot-scale manufacturing facilities to facilitate the scale-up of chemical processes. With a strong focus on quality management and innovation, the company serves as a key link in the global pharmaceutical supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 南京帝昌医药科技.